Page last updated: 2024-08-18

pyrazolanthrone and Cholangiocarcinoma

pyrazolanthrone has been researched along with Cholangiocarcinoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hong, HJ; Hwang, H; Kim, H; Lee, H1
Ai, X; Chen, X; Liang, H; Lin, Y; Lu, Y; Zhang, B1

Other Studies

2 other study(ies) available for pyrazolanthrone and Cholangiocarcinoma

ArticleYear
L1 Cell Adhesion Molecule Promotes Migration and Invasion via JNK Activation in Extrahepatic Cholangiocarcinoma Cells with Activating
    Molecules and cells, 2017, May-31, Volume: 40, Issue:5

    Topics: Anthracenes; Bile Duct Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cholangiocarcinoma; Enzyme Activation; Gene Knockdown Techniques; Humans; MAP Kinase Kinase 4; MAP Kinase Signaling System; Mutation; Neural Cell Adhesion Molecule L1; Protein Kinase Inhibitors; Proto-Oncogene Proteins p21(ras); RNA, Small Interfering

2017
JNK inhibitor SP600125 enhances TGF-β-induced apoptosis of RBE human cholangiocarcinoma cells in a Smad-dependent manner.
    Molecular medicine reports, 2013, Volume: 8, Issue:6

    Topics: Anthracenes; Apoptosis; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Caspases; Cell Line, Tumor; Cholangiocarcinoma; Enzyme Activation; Humans; JNK Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase Inhibitors; Signal Transduction; Smad Proteins; Transforming Growth Factor beta

2013